These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 16268256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of chondroitin sulfate and its interpenetrating polymer network hydrogels for sustained-drug release.
    Wang SC, Chen BH, Wang LF, Chen JS.
    Int J Pharm; 2007 Feb 01; 329(1-2):103-9. PubMed ID: 16996709
    [Abstract] [Full Text] [Related]

  • 3. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A, Kotwal V.
    AAPS PharmSciTech; 2007 Oct 19; 8(4):E88. PubMed ID: 18181548
    [Abstract] [Full Text] [Related]

  • 4. Sustained release characteristics of tablets prepared with mixed matrix of sodium carrageenan and chitosan: effect of polymer weight ratio, dissolution medium, and drug type.
    Bani-Jaber A, Al-Ghazawi M.
    Drug Dev Ind Pharm; 2005 Mar 19; 31(3):241-7. PubMed ID: 15830719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis.
    Bishnoi M, Jain A, Hurkat P, Jain SK.
    J Drug Target; 2014 Nov 19; 22(9):805-12. PubMed ID: 24955618
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nanostructured lipid carriers to enhance transdermal delivery and efficacy of diclofenac.
    Nguyen CN, Nguyen TTT, Nguyen HT, Tran TH.
    Drug Deliv Transl Res; 2017 Oct 19; 7(5):664-673. PubMed ID: 28776220
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of mucilage of Hibiscus rosasinensis Linn as rate controlling matrix for sustained release of diclofenac.
    Jani GK, Shah DP.
    Drug Dev Ind Pharm; 2008 Aug 19; 34(8):807-16. PubMed ID: 18686091
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations.
    Su SF, Chou CH, Kung CF, Huang JD.
    Int J Pharm; 2003 Jul 09; 260(1):39-46. PubMed ID: 12818808
    [Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI, Margulis EB, Sibgatullina LF, Kemenova VA, Van den Mooter G.
    Eur J Pharm Biopharm; 2008 Sep 09; 70(1):215-25. PubMed ID: 18691856
    [Abstract] [Full Text] [Related]

  • 12. Formulation in vitro and in vivo evaluation of SRMS-based heterolipid-templated homolipid delivery system for diclofenac sodium.
    Mumuni M, Attama AA, Kunle OO.
    Drug Deliv; 2016 Sep 09; 23(3):917-25. PubMed ID: 24959939
    [Abstract] [Full Text] [Related]

  • 13. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes.
    Cevc G, Blume G.
    Biochim Biophys Acta; 2001 Oct 01; 1514(2):191-205. PubMed ID: 11557020
    [Abstract] [Full Text] [Related]

  • 14. Formulation and release behavior of diclofenac sodium in Compritol 888 matrix beads encapsulated in alginate.
    Mirghani A, Idkaidek NM, Salem MS, Najib NM.
    Drug Dev Ind Pharm; 2000 Jul 01; 26(7):791-5. PubMed ID: 10872101
    [Abstract] [Full Text] [Related]

  • 15. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
    Piyakulawat P, Praphairaksit N, Chantarasiri N, Muangsin N.
    AAPS PharmSciTech; 2007 Nov 16; 8(4):E97. PubMed ID: 18181557
    [Abstract] [Full Text] [Related]

  • 16. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
    Fouad SA, Basalious EB, El-Nabarawi MA, Tayel SA.
    Int J Pharm; 2013 Sep 10; 453(2):569-78. PubMed ID: 23792042
    [Abstract] [Full Text] [Related]

  • 17. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E, De Maio V, Ronda E, Mattavelli V, Vertzoni M, Dressman JB.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):434-41. PubMed ID: 19491035
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
    Alsarra IA.
    Boll Chim Farm; 2004 Dec 28; 143(10):359-64. PubMed ID: 15881815
    [Abstract] [Full Text] [Related]

  • 19. Formulation and evaluation of diclofenac sodium using hydrophilic matrices.
    Rao YM, Veni JK, Jayasagar G.
    Drug Dev Ind Pharm; 2001 Sep 28; 27(8):759-66. PubMed ID: 11699827
    [Abstract] [Full Text] [Related]

  • 20. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya--chitosan polyelectrolyte complexes.
    Lankalapalli S, Kolapalli RM.
    Drug Dev Ind Pharm; 2012 Jul 28; 38(7):815-24. PubMed ID: 22087874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.